FOOTHILL RANCH, Calif.,
April 20, 2021 /PRNewswire/
-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in
dental lasers, and EdgeEndo, a global leader in
commercializing endodontic products, announced in association with
the American Association of Endodontists (AAE) Annual Meeting
beginning on April 21, 2021, the
co-development of EdgePRO, a next-generation Laser-Assisted
Microfluidic Irrigation device for endodontists. This new
Microfluidic Irrigation device is being developed to offer a
solution for endodontists seeking more from their current cleaning
and disinfection techniques, such as sodium hypochlorite,
ethylenediaminetetraacetic acid, chlorhexidine or 2-in-1 or 3-in-1
irrigation solutions. BIOLASE anticipates submitting a premarket
notification (510(k)) to the Food and Drug Administration for the
co-developed device in the second quarter of 2021. The device is
not currently available for sale in the
United States.
The EdgePRO Laser-Assisted Microfluidic Irrigation device will
build upon BIOLASE's patented and proven platform that has been
shown to significantly improve debridement1, cleaning
and disinfection up to 99%2-4, and removes smear
layer5-9 and biofilms10,11 using the most
advanced laser light sound technology with traditional irrigation
solutions.
"We had been researching advanced Microfluidic Irrigation
technologies in the high-tech endodontic irrigation market for
several years and concluded that BIOLASE would be an ideal business
partner for EdgeEndo," said Dr. Charles
Goodis, DDS, EdgeEndo founder and CEO. "Their proprietary
Waterlase Er,Cr:YSGG technology has proven to be clinically
effective in endodontics over the last 20 years. This is reinforced
by the publication of more than 75 research papers and the
technology's use by thousands of dentists around the world to
enhance clinical outcomes. Partnering with BIOLASE will provide us
with access to an endodontic-specific, minimally invasive
technology, with proprietary and patented radial firing tip
technology to incorporate into our EdgePRO product. We are excited
about this collaboration and in the near term look forward to
developing a technology for endodontists that has the potential to
improve patient experiences and clinical outcomes."
BIOLASE President and CEO, John
Beaver adds, "We are very pleased with the efforts thus far
on the design and performance of the EdgePRO as our first OEM laser
product. Approximately 75% of all endodontists routinely use
EdgeEndo endodontic files, burs, and bioceramics, providing reach
and relationships with the endodontists that will further our goal
of making Waterlase technology the standard of care in endodontics.
This allows BIOLASE to focus its commercial channels on other
specialties, such as periodontics and pediatrics, in addition to
the approximately 200,000 general dentists in the United States. We look forward to a long
and beneficial relationship with EdgeEndo."
Supporting the needs of endodontists is part of BIOLASE's
continued effort to help improve patient experiences and outcomes,
while also educating providers on the benefits of dental lasers.
This announcement comes on the heels of the recently developed
Waterlase Endo Academy, open to all Waterlase endodontists. Learn
more about the benefits of laser dentistry in endodontics
at biolase.com/betterendo.
About BIOLASE, Inc.
BIOLASE is a medical device company that develops, manufactures,
markets, and sells laser systems in dentistry and medicine.
BIOLASE's products advance the practice of dentistry and medicine
for patients and healthcare professionals. BIOLASE's proprietary
laser products incorporate approximately 271 patented and 40
patent-pending technologies designed to provide biologically and
clinically superior performance with less pain and faster recovery
times.
BIOLASE's innovative products provide cutting-edge technology at
competitive prices to deliver superior results for dentists and
patients. BIOLASE's principal products are revolutionary dental
laser systems that perform a broad range of dental procedures,
including cosmetic and complex surgical applications. BIOLASE has
sold over 41,200 laser systems to date in over 80 countries around
the world. Laser products under development address BIOLASE's core
dental market and other adjacent medical and consumer
applications.
For updates and information on Waterlase iPlus®, Waterlase
Express™, and laser dentistry, find BIOLASE online
at www.biolase.com, Facebook at www.facebook.com/biolase,
Twitter at www.twitter.com/biolaseinc, Instagram
at www.instagram.com/waterlase_laserdentistry, and LinkedIn
at www.linkedin.com/company/biolase.
BIOLASE®, Waterlase® and Waterlase iPlus® are registered
trademarks of BIOLASE, Inc.
1. Montero-Miralles P, Torres-Lagares D, Segura-Egea J-J,
Serrera-Figallo M-A, Gutierrez-Perez J-L, Castillo-Dali G.
Comparative study of debris and smear layer removal with EDTA and
Er,Cr:YSGG laser. Journal of Clinical and Experimental Dentistry.
2018;10(6):598-602. doi:10.4317/jced.54936
2. Juric IB, Plecko V, Anic I. Antimicrobial Efficacy of Er,Cr:YSGG
Laser-Activated Irrigation Compared with Passive Ultrasonic
Irrigation and RinsEndo((R)) Against Intracanal Enterococcus
faecalis. Photomedicine and Laser Surgery. 2014;32(11):600-605.
doi:10.1089/pho.2014.3767
3. Betancourt, Sierra, Camps-Font, Arnabat-Domínguez, Viñas.
Er,Cr:YSGG Laser-Activation Enhances Antimicrobial and Antibiofilm
Action of Low Concentrations of Sodium Hypochlorite in Root Canals.
Antibiotics. 2019;8(4):232. doi:10.3390/antibiotics8040232
4. Gordon W, Atabakhsh VA, Meza F, et al. The antimicrobial
efficacy of the Er,Cr:YSGG laser with radial emitting tips on root
canal dentin walls infected with E faecalis. JADA.
2007;138(July):992-1002. doi:10.14219/jada.archive.2007.0297
5. Silva, Anna Cristina Biella et
al. "Analysis of Permeability and Morphology of Root Canal Dentin
After Er,Cr:YSGG Laser Irradiation." Photomedicine and Laser
Surgery 28.1 (2010): 103–108. Print.
6. Madhusudhana, Koppolu et al. "Effect of Endoactivator and
Er,Cr:YSGG Laser Irradiation in Removing the Smear Layer after Root
Canal Instrumentation: An in Vitro
Study." Journal of Dr. NTR University of Health Sciences 5.1
(2016): 24. Web.
7. Soares, Flavio et al. "Impact of Er,Cr:YSGG Laser Therapy on the
Cleanliness of the Root Canal Walls of Primary Teeth." Journal of
endodontics 34.4 (2008): 474–7. Web. 25 Jan.
2012.
8. Ishizaki, Nelson Tatsunari et al. "Thermographical and
Morphological Studies of Er,Cr:YSGG Laser Irradiation on Root Canal
Walls." Photomedicine and laser surgery 22.4 (2004): 291–7.
Web.
9. Peeters, Harry Huiz, and Ketut Suardita. "Efficacy of Smear
Layer Removal at the Root Tip by Using Ethylenediaminetetraacetic
Acid and Erbium, Chromium: Yttrium, Scandium, Gallium Garnet
Laser." Journal of Endodontics 37.11 (2011): 1585–1589. Web.
10. Schoop, U et al. "The impact of an erbium,
chromium:yttrium-scandium-gallium-garnet laser with radial-firing
tips on endodontic treatment." Lasers in medical science 24.1
(2009): 59–65. Web. 5 Dec. 2011.
11. Arnabat, Josep et al. "Bactericidal Activity of Erbium,
Chromium: Yttrium–scandium–gallium–garnet Laser in Root Canals."
Lasers Medical Science 25 (2010): 805–810. Web.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biolase-and-edgeendo-announce-plans-to-develop-new-edgepro-laser-assisted-microfluidic-irrigation-device-for-endodontists-301272513.html
SOURCE BIOLASE, Inc.